Communicating about phase I trials: objective disclosures are only a first step.

about

American Society of Clinical Oncology policy statement update: the critical role of phase I trials in cancer research and treatment.

P2860

Q35894574-1FB39889-4CA0-4D84-A62A-A331F548B469

P2860

Communicating about phase I trials: objective disclosures are only a first step.

Item

http://www.wikidata.org/entity/Q43152781

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh-hant

name

Communicating about phase I trials: objective disclosures are only a first step.

@en

Communicating about phase I trials: objective disclosures are only a first step.

@nl

type

Item

label

Communicating about phase I trials: objective disclosures are only a first step.

@en

Communicating about phase I trials: objective disclosures are only a first step.

@nl

prefLabel

Communicating about phase I trials: objective disclosures are only a first step.

@en

Communicating about phase I trials: objective disclosures are only a first step.

@nl

P1476

Communicating about phase I trials: objective disclosures are only a first step.

@en

P2093

Anne Lederman Flamm

http://www.w3.org/2001/XMLSchema#string

Rebecca D Pentz

http://www.w3.org/2001/XMLSchema#string

P2860

Quality of informed consent: a new measure of understanding among research subjects.

Misunderstanding in clinical research: distinguishing therapeutic misconception, therapeutic misestimation, and therapeutic optimism.

Unrealistic optimism in early-phase oncology trials.

The therapeutic misconception: informed consent in psychiatric research.

Therapeutic misconception, misestimation, and optimism in participants enrolled in phase 1 trials.

Phase I cancer trials: a crucible of competing priorities.

Ethical issues in phase I oncology research: a comparison of investigators and institutional review board chairpersons.

Evaluation of an educational program to improve communication with patients about early-phase trial participation

Patient-physician communication in oncology: past, present, and future.

Expectations of benefit in early-phase clinical trials: implications for assessing the adequacy of informed consent

P304

466-468

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

editorial

P356

10.1634/THEONCOLOGIST.2012-0107

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2012-04-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

223972484

http://www.w3.org/2001/XMLSchema#string

P698

22491003

http://www.w3.org/2001/XMLSchema#string

P921

phase I clinical trial

P932

3336836

http://www.w3.org/2001/XMLSchema#string

Communicating about phase I trials: objective disclosures are only a first step.

about

P2860

P2860

Communicating about phase I trials: objective disclosures are only a first step.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P921

P932